rs763288862
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP4_StrongBP6
The ENST00000372923.8(DNM1):c.44G>A(p.Arg15Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000338 in 1,540,062 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R15G) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000372923.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNM1 | NM_004408.4 | c.44G>A | p.Arg15Gln | missense_variant | 1/22 | ENST00000372923.8 | NP_004399.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNM1 | ENST00000372923.8 | c.44G>A | p.Arg15Gln | missense_variant | 1/22 | 1 | NM_004408.4 | ENSP00000362014 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151854Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000258 AC: 44AN: 170260Hom.: 0 AF XY: 0.000147 AC XY: 14AN XY: 94972
GnomAD4 exome AF: 0.0000360 AC: 50AN: 1388208Hom.: 0 Cov.: 30 AF XY: 0.0000290 AC XY: 20AN XY: 689260
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151854Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74166
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 31A Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 19, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 10, 2024 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 11, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at